AMADO CASTELLON: Open Payments
NPI 1386201408 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 23 payments from 9 companies in 2025. Trend: 2023 $411 · 2024 $670 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $122 |
| Lilly USA, LLC | 3 | $70 |
| Amgen Inc. | 4 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Exact Sciences Corporation | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Philips North America LLC | 1 | $16 |
Products named: Rybelsus, OTEZLA, JARDIANCE, The Cologuard Plus Collection Kit, MOUNJARO, Ozempic, FARXIGA, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
